Best Stocks Under $3 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $3.00 (3 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. OS Therapies NYSE:OSTX$1.68 +0.15 (+9.80%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.64 -0.04 (-2.14%) As of 05/23/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS TherapiesMarket Capitalization$47.21 millionP/E Ratio-1.95Consensus RatingBuyConsensus Price Target$18.00 (+971.4% Upside)Volume220,921 sharesAverage Volume474,496 shares Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Cardiol Therapeutics NASDAQ:CRDL$1.10 +0.03 (+2.80%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.12 +0.02 (+1.82%) As of 05/23/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol TherapeuticsMarket Capitalization$90.87 millionP/E Ratio-2.82Consensus RatingBuyConsensus Price Target$8.67 (+687.9% Upside)Volume198,500 sharesAverage Volume362,805 shares3. Denison Mines NYSEAMERICAN:DNN$1.68 +0.18 (+12.00%) Closing price 05/23/2025 04:10 PM EasternExtended Trading$1.68 0.00 (-0.30%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison MinesMarket Capitalization$1.50 billionP/E Ratio-168.00Consensus RatingBuyConsensus Price Target$3.00 (+78.6% Upside)Volume156.94 million sharesAverage Volume33.46 million shares4. OnKure Therapeutics NASDAQ:OKUR$2.15 0.00 (0.00%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.17 +0.02 (+0.93%) As of 05/23/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure TherapeuticsMarket Capitalization$29.05 millionP/E Ratio-0.18Consensus RatingBuyConsensus Price Target$32.33 (+1,403.9% Upside)Volume85,095 sharesAverage Volume109,424 shares5. GeoVax Labs NASDAQ:GOVX$1.01 -0.01 (-0.98%) As of 05/23/2025 04:00 PM EasternGeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax LabsMarket Capitalization$15.35 millionP/E Ratio-0.28Consensus RatingBuyConsensus Price Target$11.10 (+999.0% Upside)Volume116,853 sharesAverage Volume527,672 shares6. Reviva Pharmaceuticals NASDAQ:RVPH$1.03 -0.02 (-1.90%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.03 +0.00 (+0.49%) As of 05/23/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva PharmaceuticalsMarket Capitalization$48.14 millionP/E Ratio-0.93Consensus RatingBuyConsensus Price Target$9.00 (+773.8% Upside)Volume242,421 sharesAverage Volume1.14 million shares7. Quince Therapeutics NASDAQ:QNCX$1.11 +0.02 (+1.83%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.08 -0.03 (-2.61%) As of 05/23/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince TherapeuticsMarket Capitalization$50.47 millionP/E Ratio-0.90Consensus RatingBuyConsensus Price Target$8.00 (+620.7% Upside)Volume160,955 sharesAverage Volume287,363 shares8. Immunic NASDAQ:IMUX$0.92 0.00 (-0.34%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.93 +0.01 (+1.24%) As of 05/23/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about ImmunicMarket Capitalization$87.92 millionP/E Ratio-0.75Consensus RatingBuyConsensus Price Target$13.00 (+1,316.7% Upside)Volume445,534 sharesAverage Volume721,856 shares9. Mereo BioPharma Group NASDAQ:MREO$2.24 -0.04 (-1.75%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.24 +0.00 (+0.22%) As of 05/23/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma GroupMarket Capitalization$362.52 millionP/E Ratio-32.00Consensus RatingBuyConsensus Price Target$7.71 (+244.4% Upside)Volume568,594 sharesAverage Volume1.12 million shares10. Rezolve AI NASDAQ:RZLV$2.11 -0.08 (-3.65%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.12 +0.01 (+0.52%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AIMarket Capitalization$439.43 millionConsensus RatingBuyConsensus Price Target$6.00 (+184.4% Upside)Volume2.99 million sharesAverage Volume5.17 million sharesToday's Range$2.06▼$2.1811. Solid Biosciences NASDAQ:SLDB$2.81 -0.08 (-2.77%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.82 +0.01 (+0.36%) As of 05/23/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Solid Biosciences Inc, a life science company, develops therapies for neuromuscular and cardiac diseases in the United States. More about Solid BiosciencesMarket Capitalization$217.82 millionP/E Ratio-0.92Consensus RatingBuyConsensus Price Target$14.90 (+430.2% Upside)Volume871,960 sharesAverage Volume1.08 million shares12. Orchestra BioMed NASDAQ:OBIO$2.72 -0.01 (-0.37%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.65 -0.07 (-2.72%) As of 05/23/2025 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Orchestra BioMed Holdings, Inc operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. More about Orchestra BioMedMarket Capitalization$104.21 millionP/E Ratio-1.69Consensus RatingBuyConsensus Price Target$14.20 (+422.1% Upside)Volume111,841 sharesAverage Volume165,530 shares13. Akebia Therapeutics NASDAQ:AKBA$2.86 +0.03 (+1.06%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.86 0.00 (-0.03%) As of 05/23/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Akebia Therapeutics, Inc, a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. More about Akebia TherapeuticsMarket Capitalization$751.14 millionP/E Ratio-12.43Consensus RatingBuyConsensus Price Target$6.63 (+131.6% Upside)Volume3.11 million sharesAverage Volume2.91 million shares14. ImmunityBio NASDAQ:IBRX$2.53 -0.15 (-5.60%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.54 +0.01 (+0.40%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. More about ImmunityBioMarket Capitalization$2.23 billionP/E Ratio-2.75Consensus RatingBuyConsensus Price Target$12.25 (+384.2% Upside)Volume6.25 million sharesAverage Volume5.58 million shares15. Genelux NASDAQ:GNLX$2.58 +0.09 (+3.61%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.60 +0.02 (+0.58%) As of 05/23/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. More about GeneluxMarket Capitalization$97.36 millionP/E Ratio-2.72Consensus RatingBuyConsensus Price Target$17.75 (+588.0% Upside)Volume56,125 sharesAverage Volume196,512 shares16. NRx Pharmaceuticals NASDAQ:NRXP$2.62 -0.07 (-2.60%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.56 -0.06 (-2.48%) As of 05/23/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NRx Pharmaceuticals, Inc, a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. More about NRx PharmaceuticalsMarket Capitalization$45.30 millionP/E Ratio-1.22Consensus RatingBuyConsensus Price Target$28.50 (+987.8% Upside)Volume183,528 sharesAverage Volume403,563 shares17. Ceragon Networks NASDAQ:CRNT$2.27 -0.06 (-2.58%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$2.28 +0.00 (+0.22%) As of 05/23/2025 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ceragon Networks Ltd., together with its subsidiaries, provides wireless transport solutions for cellular operators and other wireless service providers in North America, Europe, Africa, the Asia Pacific, the Middle East, India, and Latin America. More about Ceragon NetworksMarket Capitalization$201.87 millionP/E Ratio8.41Consensus RatingBuyConsensus Price Target$6.00 (+164.3% Upside)Volume400,310 sharesAverage Volume1.08 million shares18. Lucid Diagnostics NASDAQ:LUCD$1.59 +0.26 (+19.55%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.64 +0.04 (+2.83%) As of 05/23/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid DiagnosticsMarket Capitalization$172.02 millionP/E Ratio-1.39Consensus RatingBuyConsensus Price Target$3.50 (+120.1% Upside)Volume3.04 million sharesAverage Volume526,715 shares19. HIVE Digital Technologies NASDAQ:HIVE$1.96 -0.05 (-2.49%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$1.94 -0.02 (-1.02%) As of 05/23/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.HIVE Digital Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. The company engages in the mining and sale of digital currencies, including Ethereum Classic, Bitcoin, and other coins. More about HIVE Digital TechnologiesMarket Capitalization$347.08 millionP/E Ratio-39.20Consensus RatingBuyConsensus Price Target$7.64 (+289.9% Upside)Volume18.75 million sharesAverage Volume7.05 million shares20. Rani Therapeutics NASDAQ:RANI$0.62 -0.03 (-4.83%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.63 +0.02 (+2.79%) As of 05/23/2025 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Rani Therapeutics Holdings, Inc operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. More about Rani TherapeuticsMarket Capitalization$35.46 millionP/E Ratio-0.58Consensus RatingBuyConsensus Price Target$9.40 (+1,424.0% Upside)Volume267,982 sharesAverage Volume803,872 shares21. Stardust Power NASDAQ:SDST$0.61 0.00 (-0.12%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.60 0.00 (-0.30%) As of 05/23/2025 07:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.Market Capitalization$36.51 millionP/E Ratio-0.82Consensus RatingBuyConsensus Price Target$5.11 (+742.5% Upside)Volume226,090 sharesAverage Volume403,592 shares22. Context Therapeutics NASDAQ:CNTX$0.69 -0.01 (-1.77%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.76 +0.07 (+9.40%) As of 05/23/2025 06:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context TherapeuticsMarket Capitalization$62.16 millionP/E Ratio-0.76Consensus RatingBuyConsensus Price Target$6.00 (+765.9% Upside)Volume78,969 sharesAverage Volume285,591 shares23. FibroBiologics NASDAQ:FBLG$0.81 -0.05 (-5.81%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$0.85 +0.04 (+5.43%) As of 05/23/2025 07:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologicsMarket Capitalization$30.99 millionP/E Ratio-3.86Consensus RatingBuyConsensus Price Target$13.00 (+1,504.9% Upside)Volume203,229 sharesAverage Volume300,549 shares24. Western Copper & Gold NYSE:WRN$1.23 -0.03 (-2.38%) As of 05/23/2025 04:00 PM EasternWestern Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & GoldMarket Capitalization$252 millionP/E Ratio-61.50Consensus RatingBuyConsensus Price Target$4.25 (+245.5% Upside)Volume563,944 sharesAverage Volume372,807 shares25. Ur-Energy NYSEAMERICAN:URG$0.87 +0.16 (+22.12%) Closing price 05/23/2025 04:10 PM EasternExtended Trading$0.88 +0.01 (+1.09%) As of 05/23/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur-EnergyMarket Capitalization$316.95 millionP/E Ratio-6.70Consensus RatingBuyConsensus Price Target$2.30 (+164.2% Upside)Volume15.35 million sharesAverage Volume4.18 million shares More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Alphabet Stock Lags—But Waymo May Be Its Hidden Driver This Market Sell-Off Might Trigger a Value Rotation Into Pepsi Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
